XML 23 R4.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Statements of Operations - USD ($)
shares in Thousands, $ in Thousands
 12 Months Ended
Dec. 31, 2016
Dec. 31, 2015
Dec. 31, 2014
Revenues:      
Equipment sales $ 46,949 $ 60,099 $ 12,044
Chemicals 3,025 888 391
Consulting services and other 648 1,752 4,488
Total revenues 50,622 62,739 16,923
Operating expenses:      
Equipment sales cost of revenue, exclusive of depreciation and amortization 37,741 45,433 9,277
Chemicals cost of revenue, exclusive of depreciation and amortization 1,700 601 140
Consulting services and other cost of revenue, exclusive of depreciation and amortization 376 1,518 2,203
Payroll and benefits 12,390 23,589 20,767
Rent and occupancy 2,168 3,309 2,468
Legal and professional fees 8,293 16,604 14,430
General and administrative 3,721 6,104 6,066
Research and development, net (648) 5,362 1,521
Depreciation and amortization 979 2,019 1,865
Total operating expenses 66,720 104,539 58,737
Operating loss (16,098) (41,800) (41,814)
Other income (expense):      
Earnings from equity method investments 45,584 8,921 42,712
Royalties, related party 6,125 10,642 6,410
Interest income 268 24 74
Interest expense (5,066) (8,402) (5,725)
Litigation settlement and royalty indemnity expense, net 3,464 0 0
Other 2,463 494 26
Total other income 52,838 11,679 43,497
Income (loss) before income tax expense 36,740 (30,121) 1,683
Income tax (benefit) expense (60,938) 20 296
Net income (loss) $ 97,678 $ (30,141) $ 1,387
Earnings (loss) per common share:      
Basic (in dollars per share) $ 4.40 $ (1.37) $ 0.06
Diluted (in dollars per share) $ 4.34 $ (1.37) $ 0.06
Weighted-average number of common shares outstanding:      
Basic (in shares) 21,931 21,773 21,554
Diluted (in shares) 22,234 21,773 22,079